The present invention relates to personal care and cosmetic compositions . In particular, the present invention relates to compositions that are clear in appearance and methods of cleansing and conditioning keratinous sub strates using such clear compositions.

Cosmetic and personal care products are available in various forms and one of the forms that are desired by many consumers i s a clear aqueous product. At the same time, the consumer expects that such a product will provi de desirable cosmetic b enefits to keratinous sub strates such as hair and skin.

Further, consumers prefer products that can serve more than one function. For example, with respect to hair care, consumers generally prefer a product that can cl ean and condition their hair in a single step . Such dual functionality can often be found with water insoluble ingredients, such as, for example, oil s that condition the hair.

A sufficient amount of such oil s i s required to condition hair or skin. However, it has been difficult to provide cl ear personal care compositions that incorporate such amounts so that the compositions can serve more than one function.

Certain water-insoluble ingredients, which are oftentimes desirable for the treatment of keratinous sub strates, are inherently difficult to incorporate into aqueous systems, such as shampoos, conditioners and skin care compositions, without forming a traditional emul sion in either cream or lotion form. Oftentimes, the presence of such ingredients at levels that would impart appreciable cosmetic benefits to hair or skin and/or properties to cosmetic and personal care products result in unstable formulations resulting in undesirable phase separations in aqueous systems .

Therefore, in the formulation of clear aqueous compositions, water-insoluble compounds do not lend themselves to being used therein, due to their inability to significantly associate with the water present in the system. As a result, the presence of these water- insoluble ingredients i s generally minimal in personal care products and cosmetic products that employ aqueous systems . Thus, the difficulties in formulating such compositi ons deprives the consumer of products that can better deliver cosmeti c benefits to hair and skin such as conditioning, cleansing, coloring of hair, styling of hair, skin care, and better application and spreadability of products.

Thus, it i s desirable to provide clear compositions, such as cleansing compositions that incorporate oil s in order to provide multiple cosmetic benefits to keratinous sub strates . It is al so desirable to provide methods of cleansing and conditioning keratinous sub strates with such compositions .

The present di sclo sure i s directed to a composition compri sing : at least one alkoxylated monoamine;

at least one alkoxylated monoaci d;

at least one lipophilic compound;

at least one surfactant; and

at least one cosmetically acceptable

wherein the ratio by weight of the amount of (b) to the amount of (a) i s greater than 1 and wherein the ratio by weight of the total amount of (a) + (b) to the amount of (c) i s greater than 2.

The composition can optionally comprise at least one auxiliary ingredient (f) .

The present invention further relates to methods for cleansing and conditioning a keratinous sub strate compri sing applying the above-described composition to the keratinous sub strate.

It has been surpri singly and unexpectedly di scovered that the use of these clear compositions on keratinous sub strates, such as hair and skin, results in desirable and beneficial effects on the sub strates, for example, delivery of active ingredients, cleansing, conditioning, hair styling effects, manageability, improved shine, protection from environmental and chemical damage, and enhanced color and cosmetic effects. The term "comprising" (and its grammatical variations) as used herein is used in the inclusive sense of "having" or "including" and not in the exclusive sense of "consisting only of. The terms "a" and "the" as used herein are understood to encompass the plural as well as the singular.

Other than in the operating examples, or where otherwise indicated, all numbers expressing quantities of ingredients and/or reaction conditions are to be understood as being modified in all instances by the term "about," meaning within 10% to 15% of the indicated number.

The term lipophilic compound means those compounds which are soluble in oils and other non-polar solvents and are either completely or partially insoluble in water.

"At least one" as used herein means one or more and thus includes individual components as well as mixtures/combinations.

The term "clear" as used herein means transparent such that a person is able to see through the composition with their naked eye. The term "clear" as used herein also means that the composition does not exhibit phase separation. The term "clear" as used herein also means that the composition has visible light transmissions of at least 70 percent when measured using a commercial spectrophotometer. The term "clear" as used herein is not meant to encompass those compositions which a person cannot see through with their naked eye such as those which are pearlescent, frosted, hazy, opaque, or cloudy in appearance.

The term "silicone free" means the compositions are substantially free (that is, less than 0.25% by weight), essentially free (that is, less than 0.1% by weight), or free (that is, 0% by weight) of silicones.

The term "sulfate free" means the compositions are substantially free of sulfate-based anionic surfactants (that is, less than 0.25% by weight), essentially free of sulfate-based anionic surfactants (that is, less than 0.1 % by weight), or free (that is, 0% by weight) of sulfate-based anionic surfactants. The term "lipophilic carrier system" means a system that will deliver a lipophilic compound into an aqueous phase by incorporation or solubilization. The lipophilic carrier sy stem i s capable of bringing a lipophile into an aqueous phase such that the aqueous phase remains clear. The lipophilic carrier system includes alkoxylated monoamines and alkoxylated monoacids.

" Sub stituted," as used herein, means compri sing at least one sub stituent. Non-limiting examples of sub stituents include atoms, such as oxygen atoms and nitrogen atoms, as well as functional groups, such as hydroxyl groups, ether groups, alkoxy groups, acyloxyalkyl groups, oxyalkylene groups, polyoxyalkylene groups, carboxylic acid group s, amine groups, acylamino groups, amide groups, halogen containing groups, ester group s, thiol group s, sulphonate group s, thiosulphate group s, siloxane groups, and polysiloxane groups. The sub stituent(s) may be further sub stituted.

"Alkoxylated" as used herein means -0-CHR-(CH2)n- wherein R represents H or an alkyl group, and wherein n > 1 .

ALKOXYLATED MONOAMINES

Non-limiting examples of suitable alkoxyl ated monoamines include compounds corresponding to the formula (I) :

RN[(R' CHCH20)xH] [(R' CHCH20)yH] (I) wherein R i s linear or branched, acyclic or cyclic, saturated or unsaturated, aliphatic or aromatic, sub stituted or unsub stituted hydrocarbon radical containing at least 6 carbon atoms;

x and y, independently of one another, represent numbers of from 0 to 100;

R' represents hydrogen, or an alkyl group; and

the sum of x+y is > 0.

In formula (I), R i s linear or branched, acyclic or cyclic, saturated or unsaturated, aliphatic or aromatic, sub stituted or unsub stituted. Typically, R i s a linear or branched, acyclic alkyl or alkenyl group or an alkyl phenyl group; x and y, independently of one another, i s typically a number from 2 to 30, more typically a numb er from 1 to 25 and most typically a number from 0 to 1 5.

Examples of the alkoxylated monoamines for use in the present invention which correspond to formula (I) are PEG-2 Cocamine, PEG- 3 Cocamine, PEG-5 Cocamine, PEG- 10 Cocamine, PEG- 1 5 Cocamine, PEG-20 Cocamine, PEG-2 Lauramine, PEG- 12 Palmitamine, PEG-2 Rapeseedamine, PEG-2 Oleamine, PEG-5 Oleamine, PEG-6 Oleamine, PEG- 10 Oleamine, PEG- 1 5 Oleamine, PEG-20 Oleamine, PEG-25 Oleamine, and PEG-30 Oleamine . Other examples are alkoxylated derivatives of soyamine, stearamine and tallow amine.

Other non-limiting examples of suitable alkoxylated monoamines include compounds corresponding to formula (II) :

RNR" [(R' CHCH20)xH] (II) wherein R i s a hydrocarbon radical containing at least 6 carbon atoms;

x represents a number of from 1 to 100;

R' represents hydrogen, or an alkyl group; and

R" i s a hydrogen or a hydrocarbon radical .

In formula (II), R i s linear or branched, acyclic or cyclic, saturated or unsaturated, aliphatic or aromatic, sub stituted or unsub stituted. Typically, R i s a linear or branched, acyclic alkyl or alkenyl group or an alkyl phenyl group; x i s typically a number from 1 to 30, more typically a number from 0 to 25 and most typically a number from 0 to 1 5.

When R" in formula (II) i s a hydrocarbon radical group, thi s group may be linear or branched, saturated or unsaturated, sub stituted or unsub stituted. The hydrocarbon radical represented by R" may al so contain an alkoxylated moiety (as defined by [(R' CHCH20)yH]), and/or heteroatoms such as nitrogen. When R" contains at least one alkoxylated moiety, the total number of alkoxylation in the formula may range from 1 to 120.

Exampl es of alkoxylated monoamines for use in the present invention which correspond to formula (II) are PEG-3 Tallow Aminopropylamine, PEG- 10 Tallow Aminopropylamine, PEG- 1 5 Tallow Aminopropylamine, and PEG- 105 B ehenyl Propylenediamine.

Additional non-limiting examples of alkoxylated monoamines include compounds corresponding to formula (III) :

R(R' CHCH20)x(R' CHCH20)yNH2 (III)

wherein R i s linear or branched, acyclic or cyclic, saturated or unsaturated, aliphatic or aromatic, sub stituted or unsub stituted hydrocarbon radical containing at least 6 carbon atoms;

x and y, independently of one another, represent numbers of from 0 to 100;

R' represents hydrogen, or an alkyl group; and

the sum of x+y is > 0.

In formul a (III), R i s linear or branched, acycli c or cyclic, saturated or unsaturated, aliphatic or aromatic, sub stituted or unsub stituted. Typically, R i s a linear or branched, acyclic alkyl or alkenyl group or an alkyl phenyl group; x and y, independently of one another, i s typically a number from 2 to 30, more typically a numb er from 1 to 25 and most typically a number from 0 to 1 5.

Examples of alkoxylated monoamines for use in the present invention which correspond to formula (III) are polyetheramines containing a monoamine group . These polyetheramines are commercially available from Hunstman under the tradenames Jeffamine (M series such as M-600, M- 1000, M-2005 and M-2070) and Surfonamine series (B-60, B- 100, B-200, L- 100, L-200, L-207, L- 300) .

The at least one alkoxylated monoamine i s present in the composition in an amount of from ab out 0. 1 to about 4% by weight, such as from about 0. 1 to about 2% by weight, and from about 0.5 to about 1 % by weight, including all ranges and subranges there- between, based on the total weight of the composition.

ALKOXYLATED MONOACID S

Non-limiting examples of alkoxylated monoacids include compounds corresponding to formula (IA) : RO [CH ₂ 0]u [(CH ₂ )xCH(R' )(CH ₂ )y(CH ₂ )zO]v [CH ₂ CH ₂ 0]wCH ₂ COOH

(IA)

wherein :

R i s a hydrocarbon radical containing from about 6 to about 40 carb on atoms;

u, v and w, independently of one another, represent numbers of from 0 to 60;

x, y and z, independently of one another, represent numbers of from 0 to 13 ;

R' represents hydrogen, alkyl, and

the sum of x+y+z i s > 0;

Compounds corresponding to formula (IA) can be obtained by alkoxylation of alcohols ROH with ethylene oxide as the sole alkoxi de or with several alkoxides and sub sequent oxidation. The numbers u, v, and w each represent the degree of alkoxylation. Whereas, on a molecular level, the numbers u, v and w and the total degree of alkoxylation can only be integers, including zero, on a macroscopic level they are mean values in the form of broken numbers.

In formula (IA), R i s linear or branched, acyclic or cyclic, saturated or unsaturated, aliphatic or aromatic, sub stituted or unsub stituted. Typically, R i s a linear or branched, acyclic C6-40 alkyl or alkenyl group or a C l -40 alkyl phenyl group, more typi cally a C8-22 alkyl or alkenyl group or a C4- 1 8 alkyl phenyl group, and even more typically a C 12- 1 8 alkyl group or alkenyl group or a C6- 1 6 alkyl phenyl group; u, v, w, independently of one another, i s typically a number from 2 to 20, more typically a number from 3 to 1 7 and mo st typically a number from 5 to 1 5 ; x, y, z, independently of one another, is typically a number from 2 to 1 3 , more typically a number from 1 to 10 and most typically a number from 0 to 8.

Suitable alkoxylated monoacids of the present invention include, but are not limited to, the following representatives referred to by their INCI names (INCI : nomenclature for raw material s according to the International Cosmetic Ingredient Dictionary, 7th Edition, published by the Cosmetic, Toiletry and Fragrance Association Inc. (CTFA), Washington D.C., USA): Butoxynol-5 Carboxylic Acid, Butoxynol-19 Carboxylic Acid, Capryleth-4 Carboxylic Acid, Capryleth-6 Carboxylic Acid, Capryleth-9 Carboxylic Acid, Ceteareth-25 Carboxylic Acid, Coceth-7 Carboxylic Acid, C9-11 Pareth-6 Carboxylic Acid, CI 1-15 Pareth-7 Carboxylic Acid, C12-13 Pareth-5 Carboxylic Acid, C12-13 Pareth-8 Carboxylic Acid, C12-13 Pareth-12 Carboxylic Acid, C12-15 Pareth-7 Carboxylic Acid, C12-15 Pareth-8 Carboxylic Acid, C14-15 Pareth-8 Carboxylic Acid, Deceth-7 Carboxylic Acid, Laureth-3 Carboxylic Acid, Laureth- 4 Carboxylic Acid, Laureth-5 Carboxylic Acid, Laureth-6 Carboxylic Acid, Laureth-8 Carboxylic Acid, Laureth-10 Carboxylic Acid, Laureth-11 Carboxylic Acid, Laureth-12 Carboxylic Acid, Laureth-13 Carboxylic Acid, Laureth-14 Carboxylic Acid, Laureth-17 Carboxylic Acid, PPG-6-Laureth-6 Carboxylic Acid, PPG-8-Steareth-7 Carboxylic Acid, Myreth-3 Carboxylic Acid, Myreth-5 Carboxylic Acid, Nonoxynol-5 Carboxylic Acid, Nonoxynol-8 Carboxylic Acid, Nonoxynol-10 Carboxylic Acid, Octeth-3 Carboxylic Acid, Octoxynol- 20 Carboxylic Acid, Oleth-3 Carboxylic Acid, Oleth-6 Carboxylic Acid, Oleth-10 Carboxylic Acid, PPG-3-Deceth-2 Carboxylic Acid, Capryleth-2 Carboxylic Acid, Ceteth-13 Carboxylic Acid, Deceth-2 Carboxylic Acid, Hexeth-4 Carboxylic Acid, Isosteareth-6 Carboxylic Acid, Isosteareth-11 Carboxylic Acid, Trudeceth-3 Carboxylic Acid, Trideceth-6 Carboxylic Acid, Trideceth-8 Carboxylic Acid, Trideceth- 12 Carboxylic Acid, Trideceth-3 Carboxylic Acid, Trideceth-4 Carboxylic Acid, Trideceth-7 Carboxylic Acid, Trideceth-15 Carboxylic Acid, Trideceth-19 Carboxylic Acid, Undeceth-5 Carboxylic Acid and mixtures thereof.

The at least one alkoxylated monoacid is present in the composition in an amount of from about 0.1 to about 6% by weight, such as from about 0.5 to about 4% by weight, and from about 1 to about 2% by weight, including all ranges and subranges therebetween, based on the total weight of the composition. A preferred ratio by weight of the at least one alkoxylated monoacid to the at least one alkoxyl ated monoamine of the present invention i s greater than 1 .

LIPOPHILIC COMPOUND

The at least one lipophilic compound may, for exampl e, b e chosen from plant oil s, fatty esters, synthetic hydrocarb on oil s and hydrocarbon oil s, waxes, fatty acids and salts thereof, fatty alcohols, lipophilic vitamins and esters thereof, organic sunscreens, phospholipids, and mixtures thereof.

Non-limiting exampl es of oil s include plant oil s such as olive oil, avocado oil, coconut oil, safflower oil, almond oil, castor oil, j oj oba oil, peanut oil, sesame oil, hazelnut oil, sunfl ower oil, apricot kernel oil, grapeseed oil, palm oil, argan oil, squalane and pracaxi oil .

Non-limiting examples of synthetic oil s and hydrocarbon oil s include mineral oil, petrolatum, and C 10 - C40 hydrocarbons which may be aliphatic (with a straight, branched or cyclic chain), aromatic, arylaliphatic such as paraffins, i so-paraffins, i sododecanes, aromatic hydrocarbons, and mixtures thereof.

Non-limiting examples of waxes include paraffin wax, beeswax, candelilla wax, carnauba wax, j asmine wax, j oj ob a wax and mimo sa wax.

Suitable fatty acids include those containing from 8 to 30, preferably from 12 to 24 carbon atoms, and carboxylate salts of fatty acids. The sodium, potassium, ammonium, calcium and magnesium carboxylates of fatty acids li sted are typical examples of the carboxylate salts of the fatty acids .

Non-limiting preferred examples of fatty al cohol s include compounds of formul a:

R-OH

where R represents a hydrocarbon radical containing at least three carb on atoms, preferably from 8 to 30, more preferably from 12 to 24 carbon atoms, and which may be linear or branched, acyclic or cyclic, saturated or unsaturated, aliphatic or aromatic, sub stituted or unsubstituted. Typically, R is a linear or branched, acyclic alkyl or alkenyl group or an alkyl phenyl group.

Non-limiting preferred fatty esters include esters formed from fatty acids and C _1-10 alcohols and esters formed from the fatty alcohols as defined hereabobe and C _1-10 carboxylic acids.

In addition, non-limiting specific examples of lipophilic compounds include isopropyl palmitate, capric/caprylic triglyceride, isodecyl neopentanoate, polylsobutylene, Phloretin, Ellagic acid, Vitamin D, Vitamin E, Vitamin E Acetate, Vitamin A, Vitamin A Palmitate, 2-oleamido-l,3-octadecanediol, octyl methoxycinnamate, octyl salicylate, 18-Methyleicosanoic acid, and mixtures thereof. Other types of lipophiles include organic sunscreens, phospholipids, other water-insoluble vitamins, and other natural and synthetic oils.

According to a preferred embodiment, the at least one lipophilic compound is chosen from plant oils, hydrocarbon oils, synthetic oils, fatty acids having at least 12 carbon atoms, fatty esters and mixtures thereof.

The at least one lipophilic compound is present in the composition in an amount of from about 0.1 to about 2% by weight, such as from about 0.3 to about 1.5% by weight, and from about 0.5 to about 1.0% by weight, including all ranges and subranges therebetween, based on the total weight of the composition.

The ratio by weight of the respective amounts of the alkoxylated monoacids to the alkoxylated monoamines to the lipophilic compounds is preferably at about 2:1:1, but may be present in other ratios such as at about 1.5:1:1, at about 3:1:1, at about 4:1:1 and at about 5:1:1.

A preferred ratio by weight of the sum of the at least one alkoxylated monoamine and the at least one alkoxylated monoacid to the at least one lipophilic compound of the present invention is greater than 2. SURFACTANT

The compositions also contain at least one surfactant selected from nonionic surfactants, anionic surfactants, amphoteric surfactants, zwitterionic surfactants and mixtures thereof.

Non-limiting examples of nonionic surfactants includes alkoxylated derivatives of the following: fatty alcohols, alkyl phenols, fatty acids, fatty acid esters and fatty acid amides, wherein the alkyl chain is in the C12-50 range, typically in the C16-40 range, more typically in the C24 to C40 range, and having from about 1 to about 110 alkoxy groups. The alkoxy groups are selected from the group consisting of C2-C6 oxides and their mixtures, with ethylene oxide, propylene oxide, and their mixtures being the typical alkoxides. The alkyl chain may be linear, branched, saturated, or unsaturated. Of these alkoxylated non-ionic surfactants, the alkoxylated alcohols are typical, and the ethoxylated alcohols and propoxylated alcohols are more typical. The alkoxylated alcohols may be used alone or in mixtures with those alkoxylated materials disclosed herein-above.

Commercially available nonionic surfactants are Brij® nonionic surfactants from Croda, Inc., Edison, NJ. Typically, Brij® is the condensation products of aliphatic alcohols with from about 1 to about 54 moles of ethylene oxide, the alkyl chain of the alcohol being typically a linear chain and having from about 8 to about 22 carbon atoms, for example, Brij® 72 (i.e., Steareth-2) and Brij® 76 (i.e., Steareth-10).

Also useful herein as nonionic surfactants are alkyl glycosides, which are the condensation products of long chain alcohols, which are the condensation products of long chain alcohols, e.g. C8-C30 alcohols, with sugar or starch polymers. These compounds can be represented by the formula (S)n --0--R wherein S is a sugar moiety such as glucose, fructose, mannose, galactose, and the like; n is an integer of from about 1 to about 1000, and R is a C8-C30 alkyl group. Examples of long chain alcohols from which the alkyl group can be derived include decyl alcohol, cetyl alcohol, stearyl alcohol, lauryl alcohol, myristyl alcohol, oleyl alcohol, and the like. Preferred examples of these surfactants are alkyl polyglucosides wherein S is a glucose moiety, R is a C8-C20 alkyl group, and n is an integer of from about 1 to about 9. Commercially available examples of these surfactants include decyl polyglucoside (available as APG® 325 CS) and lauryl polyglucoside (available as APG® 600CS and 625 CS), all the above-identified polyglucosides APG® are available from Cognis, Ambler, Pa. Also useful herein sucrose ester surfactants such as sucrose cocoate and sucrose laurate.

Other nonionic surfactants suitable for use in the present invention are glyceryl esters and polyglyceryl esters, including but not limited to, glyceryl monoesters, typically glyceryl monoesters of C16- C22 saturated, unsaturated and branched chain fatty acids such as glyceryl oleate, glyceryl monostearate, glyceryl monoisostearate, glyceryl monopalmitate, glyceryl monobehenate, and mixtures thereof, and polyglyceryl esters of C16-C22 saturated, unsaturated and branched chain fatty acids, such as polyglyceryl-4 isostearate, polyglyceryl-3 oleate, polyglyceryl-2 sesquioleate, triglyceryl diisostearate, diglyceryl monooleate, tetraglyceryl monooleate, and mixtures thereof.

Also useful herein as nonionic surfactants are sorbitan esters.

Preferable are sorbitan esters of C16-C22 saturated, unsaturated and branched chain fatty acids. Because of the manner in which they are typically manufactured, these sorbitan esters usually comprise mixtures of mono-, di-, tri-, etc. esters. Representative examples of suitable sorbitan esters include sorbitan monooleate (e.g., SPAN® 80), sorbitan sesquioleate (e.g., Arlacel® 83 from Croda, Inc., Edison, NJ), sorbitan monoisostearate (e.g., CRILL® 6 from Croda, Inc., Edison, N.J.), sorbitan stearates (e.g., SPAN® 60), sorbitan trioleate (e.g., SPAN® 85), sorbitan tristearate (e.g., SPAN® 65), sorbitan dipalmitates (e.g., SPAN® 40), and sorbitan isostearate. Sorbitan monoisostearate and sorbitan sesquioleate are particularly preferred emulsifiers for use in the present invention.

Also suitable for use as nonionic surfactants are alkoxylated derivatives of glyceryl esters, sorbitan esters, and alkyl polyglycosides, wherein the alkoxy groups are selected from the group consi sting of C2-C6 oxides and their mixtures, with ethoxylated or propoxylated derivatives of these material s being typical. Nonlimiting examples of commercially available ethoxylated material s include TWEEN® (ethoxylated sorbitan mono-, di- and/or tri-esters of C 12 to C I 8 fatty acids with an average degree of ethoxylation of from about 2 to 20) .

Non-limiting examples of anionic surfactants include compounds in the classes known as alkyl sulfonates, alkyl ether sulfonates, sulfate esters of an alkylphenoxy polyoxyethylene ethanol, alpha-olefin sulfonates, b eta alkyloxy alkene sulfonates, alkyl arylsulfonates, alkyl carbonates, alkyl ether carboxylates, fatty acids, succinamates, sulfosuccinates, sarcosinates, octoxynol or nonoxynol phosphates, taurates, fatty taurides, sulfated monoglycerides, i sethionates and mixtures thereof. Specific examples of anioni c surfactants include the ammonium, monoethanolamine, diethanolamine, triethanolamine, i sopropylamine, sodium, potassium, lithium, or magnesium salts of dodecylbenzene- sulfonate, lauryl sulfosuccinate, lauryl ether carboxylate, lauryl sarcosinate, cocomethyl tauride, and sulfosuccinate half ester amide and mixtures thereof.

Non-limiting examples of amphoteric and zwitterionic surfactants include alkyl, alkyl dimethyl, alkylamido, alkyl amide, alkylamidopropyl, or alkyl dimethylammonium betaine; alky ami dopropyl or alkyl sulfobetaine; alkyl, alkylampho, or alkylamphocarb oxy glycinate; alkyl, or alkyl sub stituted imidazoline mono or dicarb oxylate; sodium salts of alkyl mono-or dicarboxylates; alkyl beta amino acids; alkyl amidopropyl, or alkyl ether hydroxysultaine; alkyl amidopropyl dimethyl ammonia acetate; alkyl ampho mono-or diacetate; alkyl, or alkyl ampho, or alkyl imino dipropionate; alkyl amphopropionate; alkyl b eta amino propionic acid; alkyl dipropionate; alkyl beta iminodipropionate; branched or n-alkyl dimethyl amidopropionate; alkyl carboxylated propionate; alkyl , or methyl alkyl imidazoline; fluorinated alkyl amphoteric mixtures; and/or nonionic surfactants such as, but not limited to, alkyl, alkyl dimethyl, alkyl amidopropylamine, or bi s 2-hydroxy ethyl alkyl amine oxides; alkanolamides; alkyl amides; polyoxy ethylene glycol (PEG) of monoglycerides, of sorbitan esters, of branched or linear fatty alcohol ethers, of branched or linear fatty acid ethers, of thioethers; alkyl oxoalcohol PEG; PEG fatty esters; polyoxyethlyene glycol/polyoxpropylene glycol block copolymers; alkyl phenol PEG ethers; alkyl polyglucosides, or poly saccarides, polysiloxane polyethoxylene ether and mixtures thereof. Specific examples include cocamidopropyl betaine, lauramidopropyl betaine, coco/ol eami dopropyl betaine, coco betaine, oleyl betaine, cocamidopropyl hydroxysultaine, tall owamidopropyl hydroxysultaine and dihydroxyethyl tallow glycinate and mixtures thereof.

The at least one surfactant i s typically present in an amount from about 0. 1 by weight to about 45% by weight, typically in an amount from about 5 by weight to about 30% by weight and more typically from about 10 by weight to 20% by weight, including all ranges and subranges there-between, based on the total weight of the composition.

AUXILIARY INGREDIENT S

The composition may optionally contain at least one auxiliary ingredient. The auxiliary ingredients may include in particular, film forming agents, proteins, amino acids, conditioning agents, cationi c polymers, skin and hair active agents, sunscreens, vi scosity modifiers, antibacterial agents, preservatives, pH adj usting agents, perfumes, sequestering agents, and mixtures thereof.

Non-limiting examples of film forming agents can be chosen from anionic compounds, non-ionic compounds, amphoteri c compounds, zwitterionic compounds, proteins, vi scosity modifiers, cationic polymers, polyamides, polyaminoamides, polyesters, silicone resins, polysaccharides, silicone fluids, polyacrylamides, starches, gums and mixtures thereof. Non-limiting examples of conditioning agents include cationi c conditioners such as quaternium-27, behenamidopropyl PG-dimonium chloride, hydroxyethyl tallowdimonium chloride, stearalkonium chloride and cetrimonium chloride . Other cationic conditioners may include those that are naturally derived.

[00090] Non-limiting examples of cationic polymers include hexadimethrine chloride, polyquaternium-4, polyquaternium-6, polyquaternium- ^■ 7, polyquaternium- 10, polyquaternium- 1 1 , polyquaternium- ■16, polyquaternium-22, polyquaternium-32, polyquaternium- ■46, polyquaternium- 5 1 , polyquaternium- 52, polyquaternium- ■53 , polyquaternium- 54, polyquaternium-55 , polyquaternium- ■56, polyquaternium- 57, polyquaternium-58, polyquaternium- ■59, polyquaternium- 60, polyquaternium-63 , polyquaternium- ■64, polyquaternium-65 , polyquaternium-66, polyquaternium- ■67, polyquaternium- 70, polyquaternium-73 , polyquaternium- ■74, polyquaternium-75 , polyquaternium-76, polyquaternium- ■77, polyquaternium-78, polyquaternium-79, polyquaternium- ■80, polyquaternium- 8 1 , polyquaternium- 82, polyquaternium- ■84, polyquaternium- 85 , polyquaternium- 86, polyquaternium- ■87, polyquaternium- 90, polyquaternium-9 1 , polyquaternium- ■92, polyquaternium- 94, and guar hydroxyproyltrimonium chloride.

The at least one skin and hair active agent includes photoprotective agents, desquamating agents, depigmenting agents, moi sturizing agents, skin lightening agents, anti-aging ingredients, anti-wrinkle agents, anti-dandruff agents and mixtures thereof. Non- limiting examples of the at least one skin active agent include a- hydroxy acids, β-hydroxy acids, a-keto acids, β-keto acids, retinoids, anthralins, anthranoids, peroxides, lithium salts, antimetabolites, vitamin D, antioxidants, ingredients that could promote moisturization and desquamating agents.

As skin and hair active agents that may be used in the composition of the present di sclo sure, examples that may b e mentioned include moi sturizers, for example, protein hydrolysates and polyols such as glycerol, glycol s, for instance polyethylene glycol s, and sugar derivatives; natural and plant extracts; anti-inflammatory agents; procyannidol oligomers; vitamins, for instancevitamin A (retinol), vitamin C (ascorbic acid), vitamin E (tocopherol), vitamin B 5 (panthenol), vitamin B 3 (niacinamide), derivatives of these vitamins (especially esters) and mixtures thereof; urea; caffeine; depigmenting agents such as koj ic acid, hydroquinone and caffeic acid; salicylic acid and its derivatives; a-hydroxy acids such as lactic acid and glycolic acid and derivatives thereof; retinoids such as carotenoids and vitamin A derivatives; sunscreens; self-tanning agents; hydrocortisone; melatonin; algal, fungal, plant, yeast or bacteri al extracts; enzymes; DHEA and its derivatives and metabolites; antibacterial active agents, for instance 2,4,4'-trichloro- 2'-hydroxydi-phenyl ether (or Triclo san), 3 , 4,4'-trichloro-carbanilide (or Triclocarban) and the acids indicated above and especially salicylic acid and its derivatives; mattifying agents and mixtures thereof.

Preferred embodiments of the compositions of the present di sclo sure include skin active agents chosen from hydroxy acids, vitamins, sunscreens, UV filters, humectants, glycol s, polyols, self- tanning ingredients, antioxidants and mixtures thereof.

Other preferred embodiments of the compositions of the present di sclo sure include skin active agents chosen from photoprotective agents, self-tanning agents, desquamating agents, depigmenting agents, moi sturizing agents, skin lightening agents, anti- aging ingredients, anti-wrinkle agents, anti-dandruff agents and mixtures thereof.

Non-limiting examples of sunscreens include benzophenones, bornelone, butyl PABA, cinnamidopropyl trimethyl ammonium chloride, di sodium di stryrylbiphenyl di sulfonate, PABA, potassium methoxycinnamate, butyl methoxydibenzoylmethane, octyl methoxycinnamate, oxybenzone, octocrylene, octyl salicyl ate, phenylbenzimidazole sulfonic acid, ethyl hydroxypropyl aminobenzoate, menthyl anthranilate, aminobenzoic acid, cinoxate, diethanolamine methoxycinnamate, glyceryl aminob enzoate, titanium dioxi de, zinc oxide, oxybenzone, ethylhexyl dimethyl PABA, red petrolatum, and mixtures thereof.

Non-limiting examples of vi scosity modifiers include water swellable/soluble cationic polymers from quaternized poly saccharides such as trimethyl ammonium sub stituted epoxide of hydroxyethyl cellulo se, diallyldimethyl ammonium salts of hydroxy ethylcellulose, deacylated chitin or chitosan, dihydroxypropyl chitosan trimonium chloride, hydroxypropltrimethyl ammonium chloride guar, locust bean, or konj ac mannan gum; quaternized synthetics such as acrylamide dimethyl diallyl ammonium chloride copolymers, acrylami de/dimethyl diallyl ammonium chloride/acrylic acid terpolymer, quaternized poly (vinyl pyrrolidone/dimethyl amino ethylmethacrylate), poly (vinylpyrrolidone/methacrylamidopropyl trim ethyl ammonium chloride), polyvinyl pyrrolidone/methylvinylimi dazolinium chloride or methyl sulfate copolymer, chloroethylether/dimethylaminopropylamine/adipate or azelate terpolymer, vinylpyrrolidone/methacrylamidopropyl trimethylammonium chloride, acrylonitril e/acrylic acid/dimethylpropanediammonium acrylates sulfate terpolymer.

Further suitable vi scosity modifiers include anioni c or nonioni c polysaccharide polymers such as gum tragacanth, sodium or propylene glycol alginate, kappa-, iota-, or lambda-carrageenan, guar or hydroxyl propyl guar gum, karaya gum, gum arabi c, locust b ean gum, konj ac mannan gum, gellan, xanthan, succinoglycan or its acidi c or enzymatic hydrolysates, sodium carboxymethyl cellulo se, methy cellulo se, hydroxyl ethyl cellulose, hydroxypropylmethylcellulo se, and hydroxypropylcellulo se; and/or hydrophobically modified anionic, cationic, or nonionic polymers such as, but not limited to, alkyl and/or sub stituted hydroxyethylcellulo se, lauryl dimethyl ammonium sub stituted epoxide of hydroxyethylcellulose, propoxylated cellulosic, xanthan, succinoglycan, or polygalactomannoses, alkyl methacrylates/crosslinked acrylic acid copolymer and/or acrylonitril e/acrylates block copolymer.

Non-limiting examples of antibacterial agents include bacitracin, phenol, benzethonium chloride, erythromycin, neomycin, tetracycline, chlortetracycline and mixtures thereof.

Non-limiting examples of preservatives include polyvinyl alcohol, phenoxyethanol, benzyl alcohol, methyl paraben, propyl paraben and mixtures thereof.

Non-limiting examples of pH adj usting agents include potassium acetate, sodium carbonate, sodium hydroxide, phosphori c acid, succinic aci d, sodium citrate, citric acid, b oric acid, lactic acid, sodium hydrogen carbonate and mixtures thereof.

The at least one auxiliary ingredient i s present in the composition in a preferred amount of from 0.001 to 50% and more preferably from 0.01 to 20% by weight, based on the total weight of the composition.

In particularly preferred embodiments of the present invention, the compositions are sub stantially free, that i s, less than 0.25%, of silicones or sulfates . Further, a pH reading of the compositions ranges from about 3 .5 to about 6.5 , such as from about 4.0 to about 4.6.

CO SMETICALLY ACCEPTIBLE CARRIER

The cosmetically acceptable carrier can be water and/or an organic solvent. Suitable organi c solvents include alcohol s, such as ethanol, i sopropyl alcohol, benzyl alcohol and phenyl ethyl alcohol ; glycol s and glycol ethers, such as propylene glycol, hexylene glycol, ethylene glycol monomethyl, monoethyl or monobutyl ether, propylene glycol and its ethers, such as propylene glycol monomethyl ether, butylene glycol, dipropylene glycol, and al so diethylene glycol alkyl ethers, such as diethylene glycol monoethyl ether and monobutyl ether; hydrocarbons such as straight chain hydrocarbons, mineral oil, polybutene, hydrogenated polyi sobutene, hydrogenated polydecene, polydecene, squalene, petrolatum and i soparaffins; and mixtures, thereof. The inventive composition can comprise a cosmetically acceptable carrier in the amount of about 95%, 90%, 80%, 70%, 60%, 50%, 40%, 30%, 20%, 10%, 5% or less b ased on the total weight of the composition. The composition can compri se a cosmetically acceptable carrier in the amount of ab out 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95 %, or more b ased on the total weight of the composition. Additionally, the amount of cosmetically acceptable carrier can be any combination of the above values, for example from ab out 20% to about 95%, or from ab out 50% to about 60% by weight based on the total weight of the compositi ons.

The compositions of the present invention contain water. The water i s typically present in an amount from ab out 50 by weight to ab out 95%) by weight, typically in an amount from about 55 by weight to about 90%) by weight and more typically from ab out 60 by weight to 85%) by weight, including all ranges and subranges there-between, based on the total weight of the compositi on.

A preferred emb odiment of the present invention i s a clear composition in the form of an oil-in-water microemul sion.

The compositions described above are useful as compositions for cleansing and conditioning keratinous sub strates . These compositions include hair care products such as shampoos and conditioners, products for cleansing and conditioning skin such as skin cleansers and personal hygiene products and products for cleaning and conditioning lips and nail s .

For exampl e, when the keratinous sub strate being treated i s hair, the compositions of the present di sclo sure may impart shine and conditioning to the hair. The compositions of the present di sclo sure can al so provide color retention properties to the artificial color in hair. In particular, the composition of the present di sclo sure may be provided in the form of a shampoo or rinse-out conditioner which preserves or inhibits the lo ss of artificial color in hair when the hair i s subj ected to one or more washings or shampooings .

Similar properties, along with styling, may be provided when the composition i s in the form of a leave-on product. The compositions of the present di sclosure may al so serve as a carrier vehicle for the auxiliary ingredients as described above.

When the keratinous sub strate i s skin, the compositions may impart protection from the sun (sunscreens) or provide skin benefits by serving as a carrier vehicle for skin actives (moi sturizing agents, anti-acne agents, anti-wrinkle agents, anti-aging agents, depigmenting agents, whitening agents, etc. ) .

The method of treatment to be provi ded will depend on the keratinous sub strate being targeted and, consequently, the specific ingredients contained in the compositi on used to effectuate the treatment. One of ordinary skill in the art will easily be able to determine these variables .

One preferred emb odiment of the present invention i s a clear cleansing composition comprising at least one alkoxylated monoamine, at least one alkoxylated monoacid, at least one lipophilic compound, at l east one surfactant, optionally, at least one auxiliary ingredient and at least one cosmetically acceptable carrier in the form of a shampoo.

Another preferred embodiment of the present invention is a clear cleansing and conditioning composition compri sing at least one alkoxylated monoamine, at least one alkoxylated monoacid, at least one lipophili c compound, at least one surfactant, optionally, at least one auxiliary ingredient and at least one cosmetically acceptable carrier in the form of a shampoo.

Another preferred embodiment of the present invention is a method of cleaning and conditioning keratinous sub strates such as hair by applying a composition comprising at least one alkoxylated monoamine, at least one alkoxylated monoacid, at least one lipophilic compound, at l east one surfactant, optionally, at least one auxiliary ingredient and at least one cosmetically acceptable carrier in the form of a shampoo.

Another preferred embodiment of the present invention is a method of cleaning and conditioning keratinous sub strates such as the skin by applying a composition compri sing at least one alkoxylated monoamine, at least one alkoxylated monoacid, at least one lipophilic compound, at l east one surfactant, optionally, at least one auxiliary ingredient and at least one cosmetically acceptable carrier in the form of a b ody wash.

Having described the subj ect matter of the present di sclo sure by way of illustration and example for purposes of clarity of understanding, it will be apparent to one of ordinary skill in the art that the same can be performed by modifying or changing the subj ect matter within a variety of conditions, formulations and other parameters without affecting its scope or any specific embodiment thereof, and that such modifications or changes are intended to be encompassed within the scope of the appended claims .

The following examples are for illustrative purposes only and are not intended to limit the scope of the claims.

EXAMPLES

EXAMPLE EXAMPLE

INCI NAME 1 2

LACTIC ACID 0.45 0.45

COCO S NUCIFERA

(COCONUT) OIL 1 .00

OLEA EUROPAEA

(OLIVE) FRUIT OIL 1 .00

FRAGRANCE 0.60 0.60

POLYMER 0.70 0.70

PRESERVATIVE 0.70 0.70

WATER 79.8 79.8

PEG-2 OLEAMINE 1 .00 1 .00

LAURETH- 1 1

CARBOXYLIC ACID 2.00 2.00

SURFACTANT S 13 .75 13 .75

TOTAL 100.00 100.00 EXAMPLE EXAMPLE

INCI NAME 3 4

LACTIC ACID 0.45 -

SQUALANE 1 .00 -

PENTACLETHRA MACROLOBA SEED OIL 0.50

FRAGRANCE 0.60 0.60

POLYMER 0.70 0.70

PRESERVATIVE 0.70 0.70

WATER 79.8 8 1 .25

PEG-2 OLEAMINE 1 .00 0.50

LAURETH- 1 1 CARB OXYLIC

ACID 2.00 2.00

SURFACTANT S 13 .75 13 .75

TOTAL 100.00 100.00

PROCEDURE :

l . In the main kettle, mixed water and polymer until fully hydrated, and heated mixture to 60-65 °C .

2. Added in the preservative and some surfactants and mixed for ab out thirty minutes until uniform.

3 . Premixed the alkoxylated monoamine, alkoxylated monoacid and lipophilic compound and heated in a water bath to 60-65 °C .

4. Added the premixed alkoxylated monoamine, alkoxylated monoacid and lipophilic compound to the main kettle and began cooling to 25 °C .

5. Added remaining surfactants and continued cooling to 25 °C .

6. At 40 °C, added fragrance and mixed well .

These examples were hair cleansing compositions that were clear in appearance and were tested on model s in a salon. The examples demonstrated the following cosmetic and styling attributes : clean, shiny, soft, easy to detangle, not weighed down hair; good manageability, good body, volume, fullness; hair was smooth, without frizz, easy to blow dry ; and had better defined curl s .

COMPARATIVE EXAMPLES : Hair cleansing compositions that are hazy in appearance.

The foregoing description illustrates and describes the present di sclo sure. Additionally, the di sclo sure shows and describes only the preferred emb odiments of the di sclo sure, but, as mentioned above, it i s to be understood that it i s capable of changes or modifications within the scope of the concept as expressed herein, commensurate with the above teachings and/or skill or knowledge of the rel evant art. The embodiments described hereinabove are further intended to explain best modes known of practicing the invention and to enable others skilled in the art to utilize the di sclosure in such, or other, embodiments and with the various modification required by the particular applications or uses di sclosed herein. Accordingly, the description i s not intended to limit the invention to the form di sclo sed herein. Al so, it i s intended that the appended claims b e construed to include alternative embodiments.

All publications, patents and patent applications cited in thi s specification are herein incorporated by reference, and for any and all purposes, as if each individual publication, patent or patent application were specifically and individually indicated to be incorporated by reference. In the case of inconsi stencies, the present di sclo sure will prevail .